title: Decrease in factor V activity: a new adverse effect of purine analogs in inflammatory bowel diseases?
authors.forename: S
authors.initials: S
authors.lastname: Poupeney
authors.forename: X
authors.initials: X
authors.lastname: Dray
authors.forename: S
authors.initials: S
authors.lastname: Reignier
authors.forename: K
authors.initials: K
authors.lastname: Vahedi
authors.forename: M
authors.initials: M
authors.lastname: Alhenc
authors.forename: S
authors.initials: S
authors.lastname: Belluci
authors.forename: P
authors.initials: P
authors.lastname: Marteau
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000009:adverse effects*; D005165:Factor V / Q000032:analysis*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000097:blood* / Q000188:drug therapy*; D015122:Mercaptopurine / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D005165:Factor V; D015122:Mercaptopurine; D001379:Azathioprine